Active, not recruiting
Rituximab, Lenalidomide, and Ibrutinib in Treating Patients With Previously Untreated Stage II-IV Follicular Lymphoma
NCT01829568
- Conditions
- Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma, +9 more
- Locations
-
- MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Roswell Park Cancer Institute Buffalo, New York, United States